Summary
In order to find out the infectious rate of hepatitis C viris (HCV) among chronic liver diseases, we investigated antibodies against hepatitis C virus and HCVRNA by method of ELISA, R1BA and RT-PCR in 410 patients with chronic liver disease. The prevalence of HCV infection was found to be 4%. Whereas the positive rate of HBsAg and HBV-DNA of these cases was 69% and 58%, respectively. There is no statistical significance between HCV infectious rate of patients with positive and negative HBsAg. The relative low infectious rate of HCV infection among chronic hepatic diseases indicates that HBV infection plays a more important role in causing chronic hepatitis than that of HCV. Thus, special emphasis should be paid to the preventive and therapeutic measures against hepatitis B in China.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Feinstone S M, Kapikan A Z, Purcell R H,et al. Transfusionassociated hepatitis not due to viral heptitis A or B. N Engl J Med, 1975;292:767–770
Alter H J, Holland P V, Morrow A Get al. Clinical and serological analysis of transfusion-associated hepatitis. Lancet, 1975;2:838–841
Alter H J, Purcell R H, Shih J W. Detection of antibody to hepatitis c virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med, 1989;321:1494–1500
Esteban J I, Gonzales A, Heranandes J M,et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med, 1990; 323:1107–1112
Kuo G, Choo Q-L, Alter Het al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science, 1989;2:297–298
Van Der Poel C L, Reesink H W, Lelie P Nel al. Anti-hepatitis C antibodies and non-A, non-B posttransfusion hepatitis in the Netherlands. Lancet, 1989;2:297–298
Miyamura T, Aaito I, Katayama Tet al. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA, 1990; 87:983–987
Chen D S, Kuo G C, Sung J Let al. HCV infection in an area hyperendemic for hepatitis and chronic liver disease: The Taiwan experience. J Infec Disea, 1990; 162:817–822
Fattovich G, Tagger A, Brollo Let al. HCV infection in chronic hepatitis B virus carriers. J Infec Disea, 1991; 163:400–402
Hansson B G, Moestup T, Widell Aet al. Infection with delta agent in Sweden: Introduction of a new hepatitis agent. J Infec Disea, 1982;146:472–478
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extration. Analytic Biochem, 1987;162:156–159
Widell A, Mansson A S, Sundstrom Get al. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C antibody assays. J Med Virol, 1991;35(4):253
McFarlane I G, Smith H M, Johanson P Jet al. HCV antibody in chronic active hepatitis: pathogenetic factor or false positive result? Lancet, 1990; 335: 754–757
Wong D C, Diwan A R, Rosen Let al. Non-specificity of anti-HCV test for seroepidemiological analysis. Lancet, 1990;336:750–751
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yong-yuan, Z., Lin-sheng, G., Yong-dong, Z. et al. Hepatitis C virus infection: Its role in chronic liver diseases. Journal of Tongji Medical University 13, 116–120 (1993). https://doi.org/10.1007/BF02887927
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02887927